Revenue (Tables)

3 Months Ended

Mar. 31, 2024

Disaggregation Of Revenue [Abstract]

Schedule of Revenue Disaggregated by Customer Type

The following table presents the Company’s revenue disaggregated by customer type (in thousands):

	Three Months Ended March 31,
	2024		2023
Pharma tests and services	$	9,812	$	6,333
Enterprise sales		7,972		9,458
Population sequencing		1,500		3,005
Other		241		64
Total revenue	$	19,525	$	18,860

Schedule of Contract Assets and Liabilities

The opening and closing balances of receivables and contract liabilities from contracts with customers are shown below (in thousands). Contract assets were immaterial for all periods presented.

	March 31, 2024		December 31, 2023
Opening balances:
Accounts receivable, net	$	17,730	$	16,642
Short-term contract liabilities	$	3,288	$	1,264
Long-term contract liabilities (included in other long-term liabilities)		3,928		—
Total contract liabilities		7,216		1,264
Closing balances:
Accounts receivable, net	$	11,345	$	17,730
Short-term contract liabilities	$	3,526	$	3,288
Long-term contract liabilities (included in other long-term liabilities)		2,097		3,928
Total contract liabilities		5,623		7,216